Table 3.
Crude and adjusted odds ratios (RR) of CDAD associated with NSAID exposure in the 90 days prior to the index date
| NSAIDS exposure in the 90 days prior to the index date | Cases | Controls | Crude | Adjusted* | |
|---|---|---|---|---|---|
| RR | RR | 95% CI | |||
| Any traditional NSAID | 462 (34.0) | 3 709 (28.4) | 1.27 | 0.97 | 0.86, 1.10 |
| Diclofenac | 96 (7.1) | 547 (4.2) | 1.63 | 1.35 | 1.10, 1.67 |
| Ibuprofen | 42 (3.1) | 446 (3.4) | 0.91 | 0.85 | 0.62, 1.15 |
| Naproxen | 12 (0.88) | 108 (0.83) | 1.06 | 0.99 | 0.56, 1.75 |
| Other traditional NSAIDs | 38 (2.8) | 262 (2.0) | 1.36 | 1.10 | 0.79, 1.51 |
| Cox-2 inhibitors | 11 (0.81) | 116 (0.89) | 0.92 | 0.77 | 0.42, 1.39 |
| Acetylsalicylic acid | 319 (23.5) | 2 656 (20.3) | 1.18 | 0.88 | 0.77, 1.01 |
Adjusted for gender, comorbidities, prescription of antibiotics, H2-receptor antagonists, proton pump inhibitors and oral steroids.